Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChina Pacific Regulatory News (CPIC)

Share Price Information for China Pacific (CPIC)

Share Price is delayed by 15 minutes
Get Live Data
26.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.80 (3.571%)
Market Cap: $51.18b
CPIC Live PriceLast checked at - London Stock Exchange

Intraday China Pacific Share Chart

  • This share is an international stock.

Estimated Increase for the First Three Quarters

15 Oct 2024 10:32

RNS Number : 2553I
China Pacific Insurance Grp Co. Ltd
15 October 2024
 

15 October 2024

CHINA PACIFIC INSURANCE (GROUP) CO., LTD.

(A joint stock company incorporated in the People's Republic of China with limited liability)

Announcement on Estimated Increase for the First Three Quarters of 2024

I. ESTIMATED RESULTS FOR THE CURRENT PERIOD

 

(I) Estimated Results Period

 

1 January 2024 to 30 September 2024.

 

(II) Estimated Results

 

Based on the preliminary estimates and calculations of the Company, it is estimated that the net profit attributable to shareholders of the parent company for the first three quarters of 2024 will range from approximately RMB37.0 billion to RMB39.4 billion, representing an increase of approximately RMB13.9 billion to RMB 16.3 billion, or approximately 60% to 70% year on year, as compared with the same period in 2023; the net profit attributable to shareholders of the parent company after deducting non-recurring items for the first three quarters of 2024 is expected to be approximately RMB36.8 billion to RMB39.1 billion, representing an increase of approximately RMB13.8 billion to RMB16.1 billion, or approximately 60% to 70% year on year, as compared with the same period in 2023.

 

(III) The estimated results have not been audited.

 

II. RESULTS OF THE SAME PERIOD OF THE PREVIOUS YEAR

 

(I) Profit before tax: RMB28.695 billion; net profit attributable to shareholders of the parent company: RMB23.149 billion; net profit attributable to shareholders of the parent company after deducting non-recurring items: RMB23.022 billion.

 

(II) Earnings per share (basic and diluted): RMB2.41.

 

III. MAIN REASONS FOR THE ESTIMATED INCREASE IN EARNINGS FOR THE CURRENT PERIOD

 

The main reason for the estimated increase in the Company's results for the first three quarters of 2024 is that the Company has maintained a certain percentage range of equity assets in its investment portfolio in accordance with its strategic asset allocation plan. Accompanied by the recent upturn in the capital market, the Company realized a significant year-on-year increase in its investment income for the first three quarters of 2024, resulting in a substantial increase in its net profit for the same period.

 

IV. RISK WARNING

 

There are no material uncertain factors of the Company that might affect the accuracy of the estimated results. Due to the fluctuation of the capital market in the future, there is uncertainty as to the increase in profit for the full year.

 

V. OTHER INFORMATION

 

The above estimates are only preliminarily calculated figures and accurate financial information will be officially disclosed in the 2024 third quarter report of the Company. Investors are advised to pay attention to investment risks.

 

 

 

 

By Order of the Board of Directors

China Pacific Insurance (Group) Co., Ltd.

FU Fan

Chairman

 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of the Market Abuse Regulation (EU) 596/2014.

 

About CPIC

CPIC is a joint stock company established under the laws of the People's Republic of China with limited liability.

CPIC's registered office is located at 1 South Zhongshan Road, Huangpu District, Shanghai, the People's Republic of China.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGPGUWUUPCUBA
Date   Source Headline
8th Jun 202612:30 pmRNSApproval of Director's Appointment Qualification
26th May 202611:05 amRNSAppointment of Vice President
20th May 202610:26 amRNSNotice of the 2025 Annual General Meeting
30th Apr 20269:50 amRNSDirector/PDMR Shareholding
28th Apr 202610:48 amRNSPublication of Summaries of Solvency Reports
28th Apr 202610:36 amRNS2026 First Quarter Report
22nd Apr 202610:35 amRNS2025 Sustainability Report
21st Apr 202611:10 amRNS2026 Q1 Results Presentation
14th Apr 202610:07 amRNSPDMR Shareholding
26th Mar 202612:32 pmRNSPublication of Annual Results Presentation
26th Mar 202612:22 pmRNSPublication of Summaries of Solvency Reports
26th Mar 202612:16 pmRNSCPIC 2025 Annual Report
18th Mar 20269:40 amRNSConvening of 2025 Annual Results Presentation
26th Jan 202611:16 amRNSApproval of Director's Appointment Qualification
19th Jan 20269:35 amRNSAnnouncement relating to Premium Income
23rd Dec 202512:55 pmRNSApproval of AoA and Dissolution of the BOS
23rd Dec 202512:55 pmRNSApproval of AoA and Dissolution of the BOS
16th Dec 20259:17 amRNSAnnouncement relating to Premium Income
9th Dec 202510:10 amRNSRelevant presentations on 2025 investor day
4th Dec 20259:58 amRNSApproval of Director's Appointment Qualification
27th Nov 20259:06 amRNSDirector Shareholding
21st Nov 20259:10 amRNSElection of Employee Director
13th Nov 20259:11 amRNSAnnouncement relating to Premium Income
30th Oct 202511:02 amRNSSummaries of the Quarterly Solvency Reports
30th Oct 20259:54 amRNS2025 Third Quarter Report
21st Oct 202510:41 amRNS2025 Q3 Results Presentation
16th Oct 202511:36 amRNSAnnouncement relating to Premium Income
19th Sep 20257:00 amRNSPublication of Offering Circular of Bonds
18th Sep 202510:51 amRNSAnnouncement relating to Premium Income
18th Sep 202510:43 amRNSCompletion of the Issue of Convertible Bonds
18th Sep 202510:40 amRNSNotice of Listing of Convertible Bonds
11th Sep 20257:00 amRNSProposed issue of Bonds under General Mandate
10th Sep 202512:24 pmRNSProposed issue of Convertible Bonds
29th Aug 202512:35 pmRNSAnnouncement on Poll Results for the EGM
28th Aug 20252:24 pmRNSResignation of Supervisor
28th Aug 20251:25 pmRNSPublication of Summaries of Solvency Reports
28th Aug 20251:24 pmRNSPublication of 2025 Interim Results Presentation
28th Aug 20251:17 pmRNS2025 Interim Report
21st Aug 202511:47 amRNSConvening of 2025 Interim Results Presentation
13th Aug 202510:50 amRNSAnnouncement relating to Premium Income
11th Aug 202511:21 amRNSNotice of EGM
30th Jul 20254:01 pmRNSAmendments to the AoA and dissolution of the BOS
15th Jul 202511:23 amRNSAnnouncement relating to Premium Income
24th Jun 202510:23 amRNSResignation of Director of the Board
13th Jun 202510:15 amRNSAnnouncement relating to Premium Income
11th Jun 202512:58 pmRNSPoll Results for the 2024 AGM
6th Jun 202510:48 amRNSApproval of Appointment Qualification
21st May 202511:19 amRNSNotice of the 2024 Annual General Meeting
14th May 202511:30 amRNSAnnouncement relating to Premium Income
12th May 202512:01 pmRNSAnnouncement relating to Change of Committee

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.